New Results
Trisomy 21 activates the kynurenine pathway via increased dosage of interferon receptors
View ORCID ProfileRani K. Powers, View ORCID ProfileKelly D. Sullivan, Rachel Culp-Hill, Michael P. Ludwig, Keith P. Smith, Katherine A. Waugh, View ORCID ProfileRoss Minter, View ORCID ProfileKathryn D. Tuttle, Hannah C. Lewis, Angela L. Rachubinski, Ross E. Granrath, Rebecca B. Wilkerson, Darcy E. Kahn, Molishree Joshi, Angelo D’Alessandro, James C. Costello, View ORCID ProfileJoaquin M. Espinosa
doi: https://doi.org/10.1101/403642
Rani K. Powers
1Linda Crnic Institute for Down Syndrome, University of Colorado Anschutz Medical Campus, Aurora, CO, USA
2Computational Bioscience Program, University of Colorado Anschutz Medical Campus, Aurora, CO, USA
3Department of Pharmacology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA
Kelly D. Sullivan
1Linda Crnic Institute for Down Syndrome, University of Colorado Anschutz Medical Campus, Aurora, CO, USA
3Department of Pharmacology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA
4Functional Genomics Facility, University of Colorado Anschutz Medical Campus, Aurora, CO, USA
5Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, CO, USA
Rachel Culp-Hill
6Department of Biochemistry and Molecular Genetics, University of Colorado Anschutz Medical Campus, Aurora, CO, USA
Michael P. Ludwig
1Linda Crnic Institute for Down Syndrome, University of Colorado Anschutz Medical Campus, Aurora, CO, USA
3Department of Pharmacology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA
Keith P. Smith
1Linda Crnic Institute for Down Syndrome, University of Colorado Anschutz Medical Campus, Aurora, CO, USA
Katherine A. Waugh
1Linda Crnic Institute for Down Syndrome, University of Colorado Anschutz Medical Campus, Aurora, CO, USA
Ross Minter
1Linda Crnic Institute for Down Syndrome, University of Colorado Anschutz Medical Campus, Aurora, CO, USA
Kathryn D. Tuttle
1Linda Crnic Institute for Down Syndrome, University of Colorado Anschutz Medical Campus, Aurora, CO, USA
Hannah C. Lewis
1Linda Crnic Institute for Down Syndrome, University of Colorado Anschutz Medical Campus, Aurora, CO, USA
Angela L. Rachubinski
1Linda Crnic Institute for Down Syndrome, University of Colorado Anschutz Medical Campus, Aurora, CO, USA
5Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, CO, USA
Ross E. Granrath
1Linda Crnic Institute for Down Syndrome, University of Colorado Anschutz Medical Campus, Aurora, CO, USA
Rebecca B. Wilkerson
6Department of Biochemistry and Molecular Genetics, University of Colorado Anschutz Medical Campus, Aurora, CO, USA
Darcy E. Kahn
1Linda Crnic Institute for Down Syndrome, University of Colorado Anschutz Medical Campus, Aurora, CO, USA
Molishree Joshi
4Functional Genomics Facility, University of Colorado Anschutz Medical Campus, Aurora, CO, USA
Angelo D’Alessandro
1Linda Crnic Institute for Down Syndrome, University of Colorado Anschutz Medical Campus, Aurora, CO, USA
6Department of Biochemistry and Molecular Genetics, University of Colorado Anschutz Medical Campus, Aurora, CO, USA
James C. Costello
2Computational Bioscience Program, University of Colorado Anschutz Medical Campus, Aurora, CO, USA
3Department of Pharmacology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA
Joaquin M. Espinosa
1Linda Crnic Institute for Down Syndrome, University of Colorado Anschutz Medical Campus, Aurora, CO, USA
3Department of Pharmacology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA
4Functional Genomics Facility, University of Colorado Anschutz Medical Campus, Aurora, CO, USA
7Department of Molecular, Cellular and Developmental Biology, University of Colorado Boulder, Boulder, CO, USA
Article usage
Posted January 11, 2019.
Trisomy 21 activates the kynurenine pathway via increased dosage of interferon receptors
Rani K. Powers, Kelly D. Sullivan, Rachel Culp-Hill, Michael P. Ludwig, Keith P. Smith, Katherine A. Waugh, Ross Minter, Kathryn D. Tuttle, Hannah C. Lewis, Angela L. Rachubinski, Ross E. Granrath, Rebecca B. Wilkerson, Darcy E. Kahn, Molishree Joshi, Angelo D’Alessandro, James C. Costello, Joaquin M. Espinosa
bioRxiv 403642; doi: https://doi.org/10.1101/403642
Trisomy 21 activates the kynurenine pathway via increased dosage of interferon receptors
Rani K. Powers, Kelly D. Sullivan, Rachel Culp-Hill, Michael P. Ludwig, Keith P. Smith, Katherine A. Waugh, Ross Minter, Kathryn D. Tuttle, Hannah C. Lewis, Angela L. Rachubinski, Ross E. Granrath, Rebecca B. Wilkerson, Darcy E. Kahn, Molishree Joshi, Angelo D’Alessandro, James C. Costello, Joaquin M. Espinosa
bioRxiv 403642; doi: https://doi.org/10.1101/403642
Subject Area
Subject Areas
- Biochemistry (11715)
- Bioengineering (8723)
- Bioinformatics (29128)
- Biophysics (14935)
- Cancer Biology (12049)
- Cell Biology (17359)
- Clinical Trials (138)
- Developmental Biology (9406)
- Ecology (14144)
- Epidemiology (2067)
- Evolutionary Biology (18268)
- Genetics (12221)
- Genomics (16767)
- Immunology (11843)
- Microbiology (28014)
- Molecular Biology (11560)
- Neuroscience (60810)
- Paleontology (450)
- Pathology (1864)
- Pharmacology and Toxicology (3231)
- Physiology (4940)
- Plant Biology (10384)
- Synthetic Biology (2878)
- Systems Biology (7333)
- Zoology (1642)